Prostate cancer remains one of the most prevalent cancers affecting men worldwide. Among the various treatment options available, hormone therapy stands out as a cornerstone in managing advanced or aggressive forms of the disease. While this treatment can be highly effective, it also comes with its share of safety concerns that patients and healthcare providers must navigate carefully.
Hormone therapy, also known as androgen deprivation therapy (ADT), works by reducing the levels of male hormones, particularly testosterone, which fuel the growth of prostate cancer cells. By depriving these cells of the hormones they need to thrive, hormone therapy aims to slow down or halt the progression of the disease. It can be administered through injections, oral medications, or surgical removal of the testicles.
Despite its efficacy, hormone therapy is associated with several safety concerns that warrant attention:
Despite the safety concerns associated with hormone therapy, it remains a crucial treatment option for many men with prostate cancer. Patients and healthcare providers can take several steps to minimize risks and optimize safety:
Hormone therapy plays a vital role in the management of prostate cancer, but it is not without its safety concerns. By understanding these risks and implementing appropriate monitoring and management strategies, patients and healthcare providers can navigate hormone therapy safely and effectively, maximizing its benefits while minimizing potential adverse effects. Open communication between patients and healthcare providers is key to ensuring that treatment decisions align with individual preferences and priorities while prioritizing safety and well-being.
BASS Cancer Center houses a diverse team of healthcare professionals, including respected medical and radiation oncologists, social workers, care coordinators, financial counselors, and patient education specialists. Our facility integrates advanced PET/CT imaging technology like the Biograph 6 and innovative treatments such as the MRI-guided MRIdian system, which optimizes radiation therapy by combining imaging and treatment in a non-invasive manner, minimizing harm to healthy tissue. We also utilize the Elekta Versa HD for precise imaging and motion management during radiation therapy.
If you'd like to learn more about hormone therapy, reach out to one of our BASS Cancer Center professionals. Contact us today to schedule a consultation and learn about the support we can provide.